%0 Journal Article
%A Giuliani, Jacopo
%A Bonetti, Andrea
%T Alectinib in first-line treatment for advanced
anaplastic lymphoma kinase mutation-positive (alk+)
non-small cell lung cancer (NSCLC): a cost-effective change
%D 2021
%R 10.1701/3620.36032
%J Recenti Progressi in Medicina
%V 112
%N 6
%P 472-475
%I Il Pensiero Scientifico Editore
%@ 2038-1840
%[ 2026/04/23
%U http://dx.doi.org/10.1701/3620.36032